Dexcom DXCM
NASDAQ DXCM
$78.32 -1.94 (-2.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012)

Updated

Dexcom (DXCM) posted Non-Current Deffered Revenue of $600,000 for Q4 2012, up 100.0% from $300,000 a year earlier and up 5.4% from the prior quarter.

Analysis

Dexcom (DXCM) Non-Current Deffered Revenue (2011 - 2012) Analysis & Trends

Since Q4 2011, Dexcom has reported Non-Current Deffered Revenue for 5 quarters.

  • In prior years, Dexcom's Non-Current Deffered Revenue was $300,000 in FY2011.
  • Quarterly Non-Current Deffered Revenue has run from a low of $300,000 in Q4 2011 to a high of $834,000 in Q1 2012 over five years.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $569,000 (Q3 2012), $702,000 (Q2 2012) and $834,000 (Q1 2012).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn -
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn -
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn -
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn -
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn -
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn -
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn -
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn -
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn -
10 Dexcom 29.72 Bn 20.04 Bn 830.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 600,000.00
Sep 30, 2012 569,000.00
Jun 30, 2012 702,000.00
Mar 31, 2012 834,000.00
Dec 31, 2011 300,000.00
API Access

Dexcom Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=DXCM&period=max&api_key=YOUR_API_KEY